Chapter 5

Competitive Position

FinVolution is a strong operator in a business with weak barriers. Set against six listed Chinese loan-facilitation peers, it is the second most profitable of the group, but its take rate, credit performance and funding are middle-of-the-pack — nothing structural separates it from rivals in its China core, where the largest peer, Qifu, earns 2.4 times its profit at a comparable loss rate. Its one durable, hard-to-copy advantage sits offshore: a multi-year overseas head start no peer has matched. On the evidence, a narrow moat.

The peer set

All six comparables run a recognisably similar model: a Cayman-listed platform that matches Chinese consumer borrowers to licensed institutional funders (banks, consumer-finance companies, trusts), takes a fee, and carries some of the credit risk through a guarantee. That shared structure is why the group is a fair mirror — and why size, not model, is what separates them.

*Lufax figures FY2025; it ran a net loss, so ROE is not meaningful and its take rate is not comparable (it is a small-business-owner and secured lender, larger-ticket than FINV's consumer micro-loans). **Lexin figures are FY2024 (its latest 20-F); all others FY2025. ROE = net income ÷ year-end shareholders' equity. Sources: FINV FY2025 20-F [1], [2], [3]; QFIN FY2025 20-F [4], [5], [6]; Lufax FY2025 20-F [7]; Lexin FY2024 20-F [8], [9], [10]; X Financial FY2025 20-F [11], [12], [13]; Jiayin FY2025 20-F [14], [15], [16]; Yiren FY2025 20-F [17], [18], [19].

Qifu is the scale leader by a distance: RMB327.1 billion of loan volume against FinVolution's RMB200.3 billion, and RMB5.99 billion of net income — 2.4 times FinVolution's RMB2.54 billion [20][21]. Below Qifu, FinVolution is the most profitable name in the group: its RMB2.54 billion tops Jiayin (RMB1.54 billion), X Financial (RMB1.46 billion), Lexin (RMB1.10 billion) and Yiren (RMB0.05 billion), and stands against a RMB1.70 billion loss at the larger Lufax [22][23][24]. That places FinVolution as a solid second — profitable, mid-scale, but not the operator others must react to.

Net income attributable to shareholders; latest fiscal year (FY2025 except Lexin FY2024). Sources as in the table above: FINV [25]; QFIN [26]; JFIN [27]; XYF [28]; LX [29]; YRD [30]; LU [31].

No structural edge in China

A moat should show up in numbers — in pricing, in credit, or in a funding cost rivals cannot match. On each of those tests FinVolution reads as competent rather than advantaged.

Pricing. Expressed as net revenue over loan volume — a rough take rate — the comparable consumer lenders cluster in a narrow band. FinVolution's 6.8% sits at the top of that band, but only just above Lexin's 6.7% and within a point of Qifu's and X Financial's 5.9%.

Derived from each company's reported net revenue and loan volume (latest fiscal year; Lexin FY2024). †Yiren's figure is flattered by non-lending revenue — roughly an eighth of its total comes from insurance brokerage and lifestyle services rather than loan facilitation. Lufax excluded (different, larger-ticket model). Sources: net-revenue and volume citations as in the peer table — FINV [32][33]; QFIN [34][35]; LX [36][37]; XYF [38][39]; JFIN [40][41]; YRD [42][43].

The narrow spread is what commoditised pricing looks like: rates are set less by any platform's brand than by the regulatory ceiling all of them face and the returns institutional funders demand. A clean loan-facilitation take rate near 7% is respectable, not a source of advantage.

Credit. On the closest like-for-like measure — the point-in-time 90-day-plus delinquency rate on the outstanding book — FinVolution again sits in the middle. Its China book ran at 2.85% at end-2025, just above Qifu's 2.71% and below Lufax's 3.4% and Lexin's 3.6% [44][45][46][47]. The remaining three report on bases that do not line up cleanly — Jiayin discloses a vintage-based M3+ rate rather than a book delinquency rate [48], and X Financial's disclosed buckets deteriorated sharply, its 91-to-180-day delinquency rate climbing to 6.31% at end-2025 from 2.48% a year earlier [49]. The read across the group is that credit is cyclically softening for everyone; FinVolution is managing it as well as the best and better than the weakest, but its underwriting is not visibly a class apart.

Funding. Every platform draws on the same pool of licensed lenders, on non-exclusive terms. FinVolution had cumulatively worked with 115 institutional funding partners in China as of end-2025 [50]; the same banks, consumer-finance companies and trusts fund its rivals, and no single partner is committed to any one platform. That is a shared, contestable input, not a proprietary one — which is why the whole group also carries credit risk on the loans it places, FinVolution included, rather than earning a pure risk-free fee [51].

The China lending economics are examined in Guarantee Economics; the point here is comparative. Nothing in pricing, credit or funding gives FinVolution an edge a well-run rival lacks. In its home market it is a good operator in a crowded, rate-capped business — which is closer to execution than to a moat.

The overseas head start

The one place the peer comparison genuinely separates FinVolution is offshore. It has built a scaled international business while the rest of the group has barely started.

FinVolution FY2025: international loan origination RMB14.0 billion (up from RMB7.9 billion in 2023), 24.6% of revenue, 5.9 million overseas unique borrowers, funded through 18 overseas institutional partners. Source: FY2025 20-F [52]; overseas revenue share per Overseas Engine.

Against that, the peer field is thin. Qifu began overseas expansion only in 2024, extending into "several overseas markets" with no overseas scale disclosed [53]. Jiayin opened an Indonesia office back in 2019 but has since disposed of its Nigeria operations and shows little overseas volume [54]. Yiren is the earliest of the followers into FinVolution's own markets, but frames the Philippines and Indonesia as businesses to "gradually expand" from a small base [55]. Lexin and X Financial were China-only in their latest filings.

Sources: FINV FY2025 20-F [56]; YRD Q4 FY2025 transcript [57]; QFIN FY2025 20-F [58]; JFIN FY2025 20-F [59]; LX FY2024 20-F [60]; XYF FY2025 20-F [61]; LU FY2025 20-F [62].

This lead is harder to copy than a China take rate. It rests on things that take years to assemble in each market: local lending licences, a repeat-borrower base (87.6% of overseas volume in 2025 came from returning borrowers), and underwriting data on populations with little formal credit history [63]. A peer entering Indonesia today starts where FinVolution stood several years and 18 funding relationships ago.

A narrow moat

The evidence points to a narrow moat. FinVolution has no structural advantage in its China core — it prices, underwrites and funds much like its rivals, and a larger peer out-earns it while reserving as conservatively. What it does have is a scaled, hard-to-replicate overseas franchise that every competitor is years behind on, and a second-place profit standing that says it executes well.

The strongest fact against calling even that a moat is size and quality of earnings. The overseas franchise, for all its lead, is still under a quarter of revenue and earns a mid-single-digit operating margin against China's high-twenties, so the durable edge is real but does not yet carry the group's profitability — the detail is in Overseas Engine. A first-mover position that does not yet earn first-mover economics is a narrow moat, not a wide one.

What would change the read in either direction is observable. Widen it: overseas operating margins converging toward China's as the borrower base seasons, which would turn a revenue lead into a profit moat. Narrow it: Yiren, Qifu or a fresh entrant reaching real scale in Indonesia or the Philippines within a few years, which would show the head start was a timing advantage rather than a barrier. Both are checkable in the segment disclosures from here.